Cite
HARVARD Citation
Xiao, W. et al. (2019). Rafoxanide, an organohalogen drug, triggers apoptosis and cell cycle arrest in multiple myeloma by enhancing DNA damage responses and suppressing the p38 MAPK pathway. Cancer letters. pp. 45-59. [Online].